Clinical Research - Among World's Top Ten
The Ministry of Enterprise, Engery and Communications, Invest in Sweden Agency, and Swecare have developed a marketing material highlighting Sweden’s competitive advantages in clinical research. The material aims to illustrate how Sweden is particularly suitable for clinical trials and we are now pleased to present the material here on our website.
Why Sweden?
- Holds the Swedish Medical Products Agency, one of Europe's foremost regulatory authorities
- Strong skills in performing clinical trials
- High quality of clinical data
- Swedish clinical research among world's top ten
Sweden offers unique assets for development and follow-up of novel prevention and treatment technology: world-renowned clinical investigators, a high proportion of health care professionals with research training, strong clinical trials know-how, health care quality registers and biobanks, patients that are keen to take part in research projects and a public health care system with universal access for all citizens.
Sweden is particularly well suited for complex trials that involve novel compounds or medical technology and which require sophisticated regulatory advice. Population-based registers and healthcare databases offer great scope for drug assessment in everyday clinical practice.
Report on Sweden’s competitive advantages for clinical development: Sweden Clinical Research
PowerPoint presentation on Sweden’s competitive advantages for clinical development: